David Lee

Evaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 Reductase

C. Locuson, M. Voice, B. Ethell, 2009, Drug Metabolism and Disposition.

Microsoft Word - 28011767-file00

M. Voice, B. Ethell, K. L. Feenstra, 2008 .

Evaluation of Escherchia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with co-expressed canine P450 reductase

M. Voice, B. Ethell, K. L. Feenstra, 2008 .

Evaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 Reductase

C. Locuson, M. Voice, B. Ethell, 2009, Drug Metabolism And Disposition.